ReignCorp
Official government records, as published. No commentary. Every entry links to its source.
Agencies › Federal Register document
2026-08-12 · Notice · Federal Register document 2026-16443

Government Owned Invention Available for License: Monoclonal Antibody (RO4) That Reacts With the Juxta-Membrane Region of Mesothelin

Health and Human Services Department, National Institutes of Health

Official abstract: The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for a novel monoclonal antibody (mAb), RO4, that can be used to treat mesothelin (MSLN) expressing cancers.

Read the full document on FederalRegister.gov →Official PDF →
More from Health and Human Services Department →More from National Institutes of Health →All federal records →